Carbonic Anhydrase Inhibitors
"Carbonic Anhydrase Inhibitors" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A class of compounds that reduces the secretion of H+ ions by the proximal kidney tubule through inhibition of CARBONIC ANHYDRASES.
Descriptor ID |
D002257
|
MeSH Number(s) |
D27.505.519.389.200
|
Concept/Terms |
Carbonic Anhydrase Inhibitors- Carbonic Anhydrase Inhibitors
- Inhibitors, Carbonic Anhydrase
- Carbonate Dehydratase Inhibitors
- Inhibitors, Carbonate Dehydratase
- Carboxyanhydrase Inhibitors
- Inhibitors, Carboxyanhydrase
|
Below are MeSH descriptors whose meaning is more general than "Carbonic Anhydrase Inhibitors".
Below are MeSH descriptors whose meaning is more specific than "Carbonic Anhydrase Inhibitors".
This graph shows the total number of publications written about "Carbonic Anhydrase Inhibitors" by people in this website by year, and whether "Carbonic Anhydrase Inhibitors" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
Year | Major Topic | Minor Topic | Total |
---|
1999 | 1 | 0 | 1 | 2004 | 0 | 2 | 2 | 2005 | 2 | 0 | 2 | 2008 | 0 | 1 | 1 | 2010 | 0 | 1 | 1 | 2011 | 0 | 2 | 2 | 2013 | 1 | 1 | 2 | 2014 | 0 | 1 | 1 | 2016 | 1 | 1 | 2 | 2017 | 1 | 0 | 1 | 2018 | 0 | 1 | 1 | 2019 | 1 | 0 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "Carbonic Anhydrase Inhibitors" by people in Profiles.
-
Hooper PL, Swenson ER, Johnson RJ. Carbonic Anhydrase Inhibitors for the Treatment of High-Altitude Hypoxemia. Am J Med. 2019 11; 132(11):e799-e800.
-
Weinreb RN, Bacharach J, Fechtner RD, Kahook MY, Wirta D, Burmaster S, Meng X, Hubatsch DA. 24-Hour Intraocular Pressure Control with Fixed-dose Combination Brinzolamide 1%/Brimonidine 0.2%: A Multicenter, Randomized Trial. Ophthalmology. 2019 08; 126(8):1095-1104.
-
Sharma S, Gralla J, Ordonez JG, Hurtado ME, Swenson ER, Schoene RB, Kelly JP, Callacondo D, Rivard C, Roncal-Jimenez C, Sirota J, Fuquay R, Jackson BP, Swenson KE, Johnson RJ, Hurtado A, Escudero E. Acetazolamide and N-acetylcysteine in the treatment of chronic mountain sickness (Monge's disease). Respir Physiol Neurobiol. 2017 12; 246:1-8.
-
Tarshis S, Maltzahn J, Loomis Z, Irwin DC. Preventing High Altitude Cerebral Edema in Rats with Repurposed Anti-Angiogenesis Pharmacotherapy. Aerosp Med Hum Perform. 2016 Dec 01; 87(12):1031-1035.
-
Hu HH, Li Z, Pokorney AL, Chia JM, Stefani N, Pipe JG, Miller JH. Assessment of cerebral blood perfusion reserve with acetazolamide using 3D spiral ASL MRI: Preliminary experience in pediatric patients. Magn Reson Imaging. 2017 Jan; 35:132-140.
-
Eigenberger P, Faino A, Maltzahn J, Lisk C, Frank E, Frank A, Loomis Z, Schroeder T, Strand M, Irwin D. A retrospective study of acute mountain sickness on Mt. Kilimanjaro using trekking company data. Aviat Space Environ Med. 2014 Nov; 85(11):1125-9.
-
Cushing T, Paterson R, Haukoos J, Harris NS. Intraocular pressure is not associated with acute mountain sickness. High Alt Med Biol. 2013 Dec; 14(4):342-5.
-
Lazcano-Gomez G, Hernandez-Oteyza A, Iriarte-Barbosa MJ, Hernandez-Garciadiego C. Topical glaucoma therapy cost in Mexico. Int Ophthalmol. 2014 Apr; 34(2):241-9.
-
Kadam RS, Jadhav G, Ogidigben M, Kompella UB. Ocular pharmacokinetics of dorzolamide and brinzolamide after single and multiple topical dosing: implications for effects on ocular blood flow. Drug Metab Dispos. 2011 Sep; 39(9):1529-37.
-
Julian CG, Subudhi AW, Wilson MJ, Dimmen AC, Pecha T, Roach RC. Acute mountain sickness, inflammation, and permeability: new insights from a blood biomarker study. J Appl Physiol (1985). 2011 Aug; 111(2):392-9.
|
People People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|